ProKidney Corp. (PROK)
1.83
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 10, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
ProKidney Total Liabilities (Quarterly) : 26.18M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.18M |
| March 31, 2026 | 29.68M |
| December 31, 2025 | 34.78M |
| September 30, 2025 | 33.27M |
| June 30, 2025 | 32.68M |
| March 31, 2025 | 36.08M |
| December 31, 2024 | 40.50M |
| September 30, 2024 | 31.32M |
| June 30, 2024 | 26.80M |
| March 31, 2024 | 24.73M |
| December 31, 2023 | 29.22M |
| Date | Value |
|---|---|
| September 30, 2023 | 23.62M |
| June 30, 2023 | 27.28M |
| March 31, 2023 | 14.17M |
| December 31, 2022 | 13.06M |
| September 30, 2022 | 11.87M |
| June 30, 2022 | 15.63M |
| March 31, 2022 | 13.11M |
| December 31, 2021 | 13.38M |
| September 30, 2021 | 7.755M |
| June 30, 2021 | 0.6031M |
| March 31, 2021 | 0.0053M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.02M |
| Shareholders Equity (Quarterly) | -883.53M |
| Debt to Equity Ratio | -0.004 |
| Current Ratio | 8.356 |
| Net Debt Paydown Yield | -0.01% |